-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 PQ9PcV/anxhlJRmPV+x7NguIjW+cpTI9QZkCkLPhFCx5xHXQlysntpONe0cBPftQ
 5yTU7c4gGn+LZwA5i4TM5A==

<SEC-DOCUMENT>0001068238-04-000673.txt : 20040402
<SEC-HEADER>0001068238-04-000673.hdr.sgml : 20040402
<ACCEPTANCE-DATETIME>20040402112704
ACCESSION NUMBER:		0001068238-04-000673
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20040401
FILED AS OF DATE:		20040402

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NUR MACROPRINTERS LTD
		CENTRAL INDEX KEY:			0000946394
		STANDARD INDUSTRIAL CLASSIFICATION:	PRINTING TRADES MACHINERY & EQUIPMENT [3555]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26498
		FILM NUMBER:		04712031

	BUSINESS ADDRESS:	
		STREET 1:		5 DAVID NAVON STREET
		STREET 2:		MOSHAV MAGSHIMIM
		CITY:			PETAH-TIKVA ISRAEL
		STATE:			L3
		ZIP:			00000
		BUSINESS PHONE:		01197239087676

	MAIL ADDRESS:	
		STREET 1:		P O BOX 8440
		STREET 2:		MOSHAV MAGSHIMIM
		CITY:			ISRAEL
		STATE:			L3
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUR ADVANCED TECHNOLOGIES LTD
		DATE OF NAME CHANGE:	19950607
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a356_form6-k.txt
<TEXT>


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 6-K

       REPORT OF FOREIGN PRIVATE ISSUED PURSUANT TO RULE 13a-16 OR 15d-16
                   UNDER THE SECURITIES EXCHANGE ACT OF 1934


                                  April 1, 2004

                        Commission File Number 000-26498


                             NUR MACROPRINTERS LTD.
             (Exact Name of Registrant as Specified in its Charter)


                                 Not Applicable
                 (Translation of Registrant's Name into English)


                          12 Abba Hillel Silver Street
                                    Lod 71111
                                     Israel
                     (Address of principal executive office)

Indicate by check mark whether the registrant  files or will file annual reports
under cover of Form 20-F or Form 40-F.

Form 20-F  |X|          Form 40-F  |_|

Indicate by check mark whether the  registrant  by  furnishing  the  information
contained  in this  Form is  also  thereby  furnishing  the  information  to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes   |_|               No  |X|

If "Yes" is marked,  include below the file number assigned to the registrant in
connection with Rule 12g3-2(b).

Attached hereto and  incorporated by reference  herein is a press release of the
registrant, dated April 1, 2004.



<PAGE>


            NUR MACROPRINTERS RECEIVES $4.5 MILLION OF EQUITY FUNDING
                                    ---------
           Includes $3.0 million from New Investors and Conversion of
                           $1.5 Million Stand-By Loan

Lod,  Israel,  April  1st 2004 - NUR  Macroprinters  (Nasdaq:  NURM),  a leading
supplier of wide-format  inkjet production  printing systems for the out-of-home
advertising market,  today announced that it has received $4.5 million of equity
funding from the sale of ordinary shares. $3 million of the funding was provided
from new investors and $1.5 million from investors who last year provided a $3.5
million stand-by convertible loan.

The new investment of $3.0 million was a private placement (or PIPE investment).
Under the PIPE investment,  NUR issued 2,586,207 of its ordinary shares at $1.16
per ordinary share. NUR expects to receive from the new investment approximately
$2.8  million,  net of expenses.  NUR also issued to the  investors  warrants to
purchase up to 646,552  ordinary shares at an exercise price of $1.54 per share.
The warrants are  exercisable  for five years from the closing date of the PIPE.
The securities offered in the PIPE have not been registered under the Securities
Act of 1933,  as  amended  (the  "Act"),  and may not be  offered or sold in the
United States absent registration, or an applicable exemption from registration,
under the Act. NUR plans to use its best  efforts to register  all  PIPE-related
shares (both those  purchased and those  issuable  pursuant to the warrants) for
resale under the Act.

Duncan Capital LLC, a NASD registered  broker dealer,  served as placement agent
for the PIPE investment.

Additional  funding was provided from  investors  who  exercised  their right to
purchase  ordinary  shares of the Company by converting $1.5 million of the $3.5
million stand-by loan. The conversion  price was $0.62 per share,  approximately
20% higher than the NUR's stock price at the time it accepted the investor  term
sheet in mid-2003. The investors previously converted the remaining $2.0 million
of the standing loan on December 31, 2003.

Mr.  Dan  Purjes,  Chairman  of the Board  and a  majority  shareholder  in NUR,
participated in this stand-by loan in approximately  the amount of $1.3 million.
Mr. Purjes exercised his right to convert $0.9 million of the standing loan. Mr.
Purjes had  previously  converted  $0.4 million of the standing loan on December
31, 2003

This  equity  investment  was  initiated  by NUR in order to improve its working
capital and to meet an anticipated increase in manufacturing volumes in 2004. As
an inducement  for  conversion,  NUR offered to register the shares issued under
the conversion as soon as possible.

Commenting on the equity funding,  Dan Purjes,  Chairman of the Board, said, "As
our company  ramps up to meet the growing  demand for our  equipment and develop
state of the art digital tools to meet our market's needs,  the additional funds
from the PIPE and the stand-by financings will


<PAGE>

facilitate  our  growth  efforts.  We plan to use these  resources  to  maximize
shareholder value. I am pleased to have participated meaningfully in this equity
financing."

David Amir, NUR Macroprinter's President and CEO, stated, "The commitment of the
new  investors and the  conversion  of the stand-by  loan by existing  investors
demonstrates  support  for  our  strategic  growth  plans.  We look  forward  to
optimizing our efforts to increases sales within our target markets."

About NUR Macroprinters Ltd.

NUR  Macroprinters  (Nasdaq:  NURM) is a leading supplier of wide-format  inkjet
printing systems used for the production of out-of-home  advertising  materials.
From entry-level photo-realistic printers to high-throughput production presses,
NUR's complete line of cost-effective, reliable printing solutions and companion
inks are helping  customers  in over 100  countries  worldwide  address the full
spectrum  of  wide-format  printing  requirements.   NUR  customers,   including
commercial printing  companies,  sign printers,  screen printers,  billboard and
media companies,  photo labs, and digital printing service  providers,  count on
NUR to help them deliver the high quality and fast  turnaround they need to meet
their clients' exacting demands and succeed in today's competitive marketplace.

More information about NUR Macroprinters is available at www.nur.com.

SAFE  HARBOR:  Certain  statements  made herein  that use the words  "estimate,"
"project," "intend," "expect," "believe" and similar expressions are intended to
identify forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These  forward-looking  statements  involve known
and  unknown  risks and  uncertainties  that  could  cause the  actual  results,
performance or achievements of NUR Macroprinters Ltd. To be materially different
from those  which may be  expressed  or implied by such  statements,  including,
among  others,   changes  in  general  economic  and  business   conditions  and
specifically,  decline in demand for NUR Macroprinters Ltd's products, inability
to timely develop and introduce new technologies,  products and applications and
loss of market  share and pressure on prices  resulting  from  competition.  For
additional  information  regarding  these  and  other  risks  and  uncertainties
associated with the Company's  business,  reference is made to NUR Macroprinters
Ltd.'s  reports  filed  from  time to time  with  the  Securities  and  Exchange
Commission.    This   press   release   is   available   at   www.nur.com    and
www.portfoliopr.com.

                                       ###
CONTACTS:
NUR MACROPRINTERS:   David Seligman
                     011 972-67-726-559
                     cfo@nur.com
                     -----------

PORTFOLIO PR:        Paul Holm/Jerry Cahn
                     212-736-9224
                     pholm@portfoliopr.com / jcahn@portfoliopr.com
                     ---------------------   ---------------------


<PAGE>


                                   SIGNATURES


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned, thereunto authorized.


                                                      NUR MACROPRINTERS LTD.


Date: April 2, 2004                                   By:  /s/ DAVID AMIR
                                                        ------------------------
                                                        David Amir
                                                        Chief Executive Officer


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
